ElsaLys Biotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

ElsaLys Biotech General Information

Description

Operator of a clinical-stage immuno-oncology company based in Lyon, France. The company designs and develops a new generation of therapeutic antibodies that target tumors and their immune and/or vascular microenvironment.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 317 Avenue Jean Jaurès
  • 69007 Lyon
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 317 Avenue Jean Jaurès
  • 69007 Lyon
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ElsaLys Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ElsaLys Biotech‘s full profile, request access.

Request a free trial

ElsaLys Biotech Patents

ElsaLys Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3048799-A1 Compounds binding human cd160 and uses thereof Pending 06-Jan-2017
EP-3565593-A1 Compounds binding human cd160 and uses thereof Inactive 06-Jan-2017
US-10975159-B2 Compounds binding human cd160 and uses thereof Inactive 06-Jan-2017
US-20200109211-A1 Compounds binding human cd160 and uses thereof Active 06-Jan-2017
WO-2018127586-A1 Compounds binding human cd160 and uses thereof Inactive 06-Jan-2017 C07K16/2896
To view ElsaLys Biotech’s complete patent history, request access »

ElsaLys Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ElsaLys Biotech Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ElsaLys Biotech‘s full profile, request access.

Request a free trial

ElsaLys Biotech FAQs

  • When was ElsaLys Biotech founded?

    ElsaLys Biotech was founded in 2013.

  • Where is ElsaLys Biotech headquartered?

    ElsaLys Biotech is headquartered in Lyon, France.

  • What is the size of ElsaLys Biotech?

    ElsaLys Biotech has 14 total employees.

  • What industry is ElsaLys Biotech in?

    ElsaLys Biotech’s primary industry is Drug Discovery.

  • Is ElsaLys Biotech a private or public company?

    ElsaLys Biotech is a Private company.

  • What is ElsaLys Biotech’s current revenue?

    The current revenue for ElsaLys Biotech is .

  • How much funding has ElsaLys Biotech raised over time?

    ElsaLys Biotech has raised $5.76M.

  • Who are ElsaLys Biotech’s investors?

    Alsace BioValley, Bpifrance, Credit Agricole, Institut Mérieux, and SEMIA Incubateur d' Alsace are 5 of 7 investors who have invested in ElsaLys Biotech.

  • When was ElsaLys Biotech acquired?

    ElsaLys Biotech was acquired on 07-May-2020.

  • Who acquired ElsaLys Biotech?

    ElsaLys Biotech was acquired by Mediolanum Farmaceutici.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process